The correlation of drug concentration and side effect/clinical efficacy in the use of liposomal amphotericin B after hematopoietic cell transplantation

The correlation of drug concentration and side effect/clinical efficacy in the use of liposomal amphotericin B after hematopoietic cell transplantation - AMB conc. after HCT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017283

Enrollment

100

Registered

2015-05-01

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients treated with liposomal amphotericin B for invasive fungal infection after allogeneic hematopoietic cell transplantation at Toranomon Hospital or Toranomon Hospital Kajigaya

Exclusion criteria

Exclusion criteria: Patients who have allergy to amphotericin B or liposomal amphotericin B

Design outcomes

Primary

Measure	Time frame
Drug concentration of liposomal amphotericin B (trough, peak)	—

Secondary

Measure	Time frame
Side effect and clinical efficacy of liposomal amphotericin B	—

Countries

Japan

Contacts

Public ContactShinsuke Takagi

Toranomon Hospital Department of Hematology

shinsuke-takagi@umin.net03-3588-1111

Outcome results